{"id":410589,"title":"Incorporation by Reference List #1: List of new drugs for expanded indication in relation to the COVID-19 pandemic  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-13","captureTimestamp":"2026-01-13T01:39:44.242000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/expanded-indication.html","snippet":"List of new drugs for expanded indication in relation to the COVID-19 pandemic Under the interim order , the Minister of Health may permit the sale of a previously approved new drug for a new indication (use) that has not yet been authorized in Canada. The manufacturer does not…","rawSnapshotUrl":"/api/snapshots/raw/410589","browseUrl":"https://replay.healtharchive.ca/job-6/20260113013944/https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/expanded-indication.html#ha_snapshot=410589","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}